SIGN UP
LOG IN
L
02157
Lepu Biopharma
4.36
0.55+14.44%Closed16:08 03/31 HKT
OPEN/PREV CLOSE3.920/4.360
TODAY RANGE3.770-4.500
VOL100.96M
MARKET CAP7.46B
52 WEEK RANGE2.160-6.500
AVG VOL (3M)12.59M
% TURNOVER5.90%
TURNOVER425.71M
P/E (TTM)-16.789
% RANGE19.16%
EPS(TTM)-0.260
P/E(FORWARD)-25.452
P/B9.826
BVPS0.444
DIVIDEND--
P/S366.387
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP7.22B
SHARES OUTSTANDING1.71B
NEXT EARNINGS--
FREE FLOAT1.66B
LOT SIZE1000
EX-DIV DATE--
News
Press Releases
Financial Reports
Profile
Reuters·4d ago
LEPU BIOPHARMA FY REVENUE RMB 300.3 MILLION
Reuters·01/22 00:00
LEPU BIOPHARMA - DEAL WITH ARRIVENT BIOPHARMA, INC
Reuters·01/22 00:00
LEPU BIOPHARMA CO LTD -EXCLUSIVE LICENSE AGREEMENT FOR NOVEL ADC MRG007
Reuters·08/21/2024 09:54
LEPU BIOPHARMA H1 REVENUE RMB 94.8 MILLION
Same Industry
Name/Symbol
Change%
Price
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
② More than 40M Downloads Globally : data based on Webull Technologies Limited's internal statistics as of July 14, 2023.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
② More than 40M Downloads Globally : data based on Webull Technologies Limited's internal statistics as of July 14, 2023.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.